CU23480B7 - METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE RELIABLE OBTAINING OF ACCEPTABLE LEVELS OF TESTOSTERONE IN SERUM - Google Patents
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE RELIABLE OBTAINING OF ACCEPTABLE LEVELS OF TESTOSTERONE IN SERUMInfo
- Publication number
- CU23480B7 CU23480B7 CU20050166A CU20050166A CU23480B7 CU 23480 B7 CU23480 B7 CU 23480B7 CU 20050166 A CU20050166 A CU 20050166A CU 20050166 A CU20050166 A CU 20050166A CU 23480 B7 CU23480 B7 CU 23480B7
- Authority
- CU
- Cuba
- Prior art keywords
- testosterone
- serum
- pharmaceutical compositions
- acceptable levels
- methods
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se relaciona con composiciones farmacéuticas, formuladas para administración inyectable, la cual comprende un éster de testosterona, en particular undecanoato de testosterona, en un vehículo que comprende aceite de castor y un co-solvente. Posterior a inyectar la composición de acuerdo a un esquema de administración particular, niveles aceptables de testosaterona en suero en un rango fisiológicamente normal es logrado por un largo período. Esto permite el uso de las composiciones en terapia de reemplazo hormonal y anticoncepción masculina sin monitoreo concominante de los niveles de testosterona en suero de un individuoThe present invention relates to pharmaceutical compositions, formulated for injectable administration, which comprises a testosterone ester, in particular testosterone undecanoate, in a vehicle comprising castor oil and a co-solvent. After injecting the composition according to a particular administration schedule, acceptable levels of serum testosaterone in a physiologically normal range is achieved for a long period. This allows the use of the compositions in hormone replacement therapy and male contraception without concomitant monitoring of the serum testosterone levels of an individual
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20050166A CU23480B7 (en) | 2005-09-12 | 2005-09-12 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE RELIABLE OBTAINING OF ACCEPTABLE LEVELS OF TESTOSTERONE IN SERUM |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20050166A CU23480B7 (en) | 2005-09-12 | 2005-09-12 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE RELIABLE OBTAINING OF ACCEPTABLE LEVELS OF TESTOSTERONE IN SERUM |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU23480B7 true CU23480B7 (en) | 2010-01-22 |
Family
ID=41694890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20050166A CU23480B7 (en) | 2005-09-12 | 2005-09-12 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE RELIABLE OBTAINING OF ACCEPTABLE LEVELS OF TESTOSTERONE IN SERUM |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU23480B7 (en) |
-
2005
- 2005-09-12 CU CU20050166A patent/CU23480B7/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP056095A (en) | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE RELIABLE OBTAINING OF ACCEPTABLE LEVELS OF TESTOSTERONE IN SERUM | |
| ECSP034654A (en) | STEROID HORMONE PRODUCTS AND METHODS TO PREPARE THE SAME | |
| ES2524320T3 (en) | Composition for the prevention or treatment of disease associated with thrombus or embolus | |
| CR11789A (en) | ORAL FORMULATIONS OF CITIDINE ANALOGS AND METHODS FOR THE USE OF THE SAME | |
| AR107285A2 (en) | VACCINE | |
| CU20060153A7 (en) | NEW CRYSTAL FORM V AGOMELATINE, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| UY28862A1 (en) | NEW PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SEXUAL DISORDERS II | |
| BRPI0516830A (en) | conveniently implantable sustained release drug compositions | |
| CL2008002720A1 (en) | Transdermic pharmaceutical composition for nebulizing, without alcohol, comprising one or more drugs, the enhancers of transdermal penetration diethylene glycol ethers or ester sunscreens, and non-volatile liquids; measured nebulization dosing device comprising it; manufacturing method; And its use. | |
| HN2008000621A (en) | METHOD FOR PREVENTIVE HORMONAL ANTICOPCEPTION UNDER DEMAND | |
| AR057060A1 (en) | TANAPROGET COMPOSITIONS CONTAINING ETHYL ESTRADIOL | |
| CR10489A (en) | PHENYL-PIRAZOL DERIVATIVES AS LEGANDS OF NON-STEROID GLUCOCORTICOID RECEPTORS | |
| PE20091949A1 (en) | SOLID PHARMACEUTICAL FORMULATION WITH DELAYED RELEASE | |
| UY30462A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING A TETRAHYDROPHOLIC ACID. | |
| BR112012010083B8 (en) | Sustained-release topical pharmaceutical composition and related use | |
| CR9616A (en) | NEW INJECTABLE COMPOSITIONS AND PROCEDURE FOR THE PREPARATION OF SUCH COMPOSITIONS | |
| CL2008000876A1 (en) | PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC USE THAT INCLUDES A PHOSPHOLIPID COMPONENT COMPOSED BY BIPOLAR PHOSPHOLIPIDS OF NATURAL ORIGIN AND AN OLEOUS COMPONENT COMPOSED BY NATURAL OIL ORIGINS EMULSIONED IN WATER; PREPARATION PROCEDURE | |
| HRP20160108T1 (en) | Use of testosterone and a 5-ht1a agonist in the treatment of sexual dysfunction | |
| PE20070188A1 (en) | CONJUGATED ESTROGEN AND BAZEDOXIFENE FORMULATIONS | |
| ECSP034624A (en) | COMBINATION OF GAVA AGONIST AND INHIBITORS OF SORBITOL-DESHIDROGENASA | |
| MX338110B (en) | Formulations comprising triptan compounds. | |
| MX2009010989A (en) | Lyophilized pharmaceutical compositions and methods of making and using same. | |
| PE20211588A1 (en) | COMPOUNDS AND THEIR USES TO RELIEVE SYMPTOMS ASSOCIATED WITH MENOPAUSE | |
| PE20040068A1 (en) | ETONOGESTREL DECANOATE, UNDECANOATE AND DODECANOATE | |
| CO6280503A2 (en) | NEURTURINE CONJUGATES NEW FOR PHARMACEUTICAL USE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant of patent |